These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 41416)

  • 1. Autoimmune response to acetylcholine receptors in myasthenia gravis and its animal model.
    Lindstrom J
    Adv Immunol; 1979; 27():1-50. PubMed ID: 41416
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors.
    Lennon VA; Lambert EH
    Nature; 1980 May; 285(5762):238-40. PubMed ID: 6154894
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Animal model for myasthenia gravis: acetylcholine receptor-induced myasthenia in rabbits, guinea pigs and monkeys.
    Tarrab-Hazdai R; Aharonov A; Abramsky O; Silman I; Fuchs S
    Isr J Med Sci; 1975 Dec; 11(12):1390. PubMed ID: 815200
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunology of the nicotinic acetylcholine receptor.
    Fuchs S
    Curr Top Microbiol Immunol; 1979; 85():1-29. PubMed ID: 114357
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding affinities of anti-acetylcholine receptor autoantibodies in myasthenia gravis.
    Bray JJ; Drachman DB
    J Immunol; 1982 Jan; 128(1):105-10. PubMed ID: 7054275
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor.
    Wang ZY; Qiao J; Link H
    J Neuroimmunol; 1993 May; 44(2):209-14. PubMed ID: 8505410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acetylcholine receptors and myasthenia gravis].
    Yagi K; Uono M
    Nihon Rinsho; 1979; 37(8):3115-24. PubMed ID: 390183
    [No Abstract]   [Full Text] [Related]  

  • 9. Acetylcholine receptor antibody-mediated animal models of myasthenia gravis and the role of complement.
    Kusner LL; Sengupta M; Kaminski HJ
    Ann N Y Acad Sci; 2018 Feb; 1413(1):136-142. PubMed ID: 29356015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A form of acute experimental autoimmune myasthenia gravis in mice occurring in absence of detectable circulating anti-acetylcholine receptor antibodies. Acute experimental myasthenia in mice.
    Granato D; Piguet PF; Fulpius BW
    J Neurol Sci; 1980 Sep; 47(3):379-83. PubMed ID: 7420113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis.
    Yoshikawa H; Lambert EH; Walser-Kuntz DR; Yasukawa Y; McCormick DJ; Lennon VA
    J Immunol; 1997 Aug; 159(3):1570-7. PubMed ID: 9233656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological similarities between an experimental autoimmune myasthenia gravis model and human myasthenia gravis.
    Souan ML; Geffard M
    Neurosci Lett; 1986 Aug; 68(3):282-7. PubMed ID: 2427976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 15. Purification of high-affinity Fab fragments from experimental autoimmune myasthenia gravis rabbits and their effect on isolated acetylcholine receptors.
    Mihovilovic M; Martinez-Carrion M
    Biochemistry; 1979 Oct; 18(21):4522-8. PubMed ID: 497153
    [No Abstract]   [Full Text] [Related]  

  • 16. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor.
    Barchan D; Asher O; Tzartos SJ; Fuchs S; Souroujon MC
    Eur J Immunol; 1998 Feb; 28(2):616-24. PubMed ID: 9521072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogenesis of myasthenia gravis.
    Fulpius BW
    Bull Schweiz Akad Med Wiss; 1978 Mar; 34(1-3):25-31. PubMed ID: 667413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anti-idiotopic antibody on the course of experimental autoimmune myasthenia gravis.
    Agius MA; Yuen E
    Ann N Y Acad Sci; 1998 May; 841():584-6. PubMed ID: 9668301
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune antireceptor diseases.
    Stobo JD
    Hosp Pract (Hosp Ed); 1981 Mar; 16(3):49-56. PubMed ID: 6259048
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune response.
    Wauben MH; Hoedemaekers AC; Graus YM; Wagenaar JP; van Eden W; de Baets MH
    Eur J Immunol; 1996 Dec; 26(12):2866-75. PubMed ID: 8977279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.